1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
National Cancer Institute (NCI) SBIR/STTR Grants is a grant from the National Cancer Institute (NCI) of NIH that funds small businesses developing innovative cancer-related technologies and treatments. The program supports both SBIR (company-led) and STTR (research institution partnership) projects through investigator-initiated grants and NCI-defined contracts.
Phase I grants are approximately $300,000 and Phase II awards exceed $2 million. Grant submissions are accepted three times per year; contracts are accepted once annually and focus on NCI priority areas. Eligible applicants are small businesses meeting NIH SBIR/STTR requirements proposing projects within NIH's research mission.
Note: NIH SBIR/STTR legislative authority expired October 1, 2025; check NCI's site for current status.
Get alerted about grants like this
Get emailed when new opportunities from “National Cancer Institute (NCI) of NIH” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Funding - NCI NIH has no active Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) solicitations because the legislative authority for the programs expired on October 1, 2025. Current recipients should direct any questions to their Program Officer. See NOT-OD-26-006 .
NCI SBIR/STTR Small Business Funding Researcher-initiated projects that are within the National Institutes of Health’s (NIH) mission can receive small business funding, resources, and support from the NCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding is primarily awarded through either a grant or a contract, though supplemental awards are also available.
Grants are investigator-initiated, whereas contracts are defined by NIH. Grant submissions are accepted three times per year, except for targeted solicitations, which have variable receipt dates. Contract submissions are accepted only once per year and focus on NCI priority areas.
Contracts are awarded to projects that have a strong potential for commercial success, and development progresses with significant oversight from NCI. The NCI SBIR Contract funding is a unique funding opportunity that involved NCI-defined requirements, deliverables, and schedule.
NCI SBIR/STTR Supplement Awards Small Business Application Process and Resources Application resources are available to small businesses so they can apply for Phase I SBIR/STTR funding.
According to the current listing, eligibility includes: Most grant requirements allow applications with an investigator-defined scope within the mission of NIH. Small businesses must meet general NIH SBIR/STTR eligibility requirements. Confirm the full requirements in the official notice before applying.
The current listing shows varies by phase (e.g., ~$300k for Phase I, ~$2M+ for Phase II). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for National Cancer Institute (NCI) SBIR/STTR Grants are due September 5, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
National Cancer Institute (NCI) SBIR/STTR Grants is funded by National Cancer Institute (NCI) of NIH. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Minnesota Ovarian Cancer Alliance National Early Detection of Ovarian Cancer Research Awards 2026 is sponsored by Minnesota Ovarian Cancer Alliance (MOCA). MOCA will award multiple grants to support research on the early detection of ovarian, primary peritoneal, or fallopian tube cancer. Project funding is available for one year of activity.
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM is sponsored by National Cancer Institute (NCI). This Phase I SBIR contract solicitation from the NCI invites small businesses to submit research proposals for early-stage, innovative, and transformative technologies addressing rare and/or pediatric cancers. The program supports demonstrating proof-of-concept and feasibility.
NOT-OD-26-112 released a draft NIH Biosafety Policy for Research Involving Biohazards on August 19, 2026. It would replace the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, extend IBC jurisdiction from engineered molecules to wild-type agents, toxins and prions, impose 24-hour incident reporting, and make the Biosafety Officer a federally defined role. Here is what actually changes and how to respond before the October 19, 2026 deadline.
Read articleNIH released a draft policy on August 27, 2026 that would require every NIH-supported clinical study to offer participants a plain-language summary of results — clinical trials within one year of completion, all other clinical research by the end of the funding period. It covers observational and behavioral research that ClinicalTrials.gov never touched. Here is the scope, the four requirements nobody has budgeted for, and what to say before the October 26 deadline.
Read articleUSDA and HHS announced Harvest to Hallways on August 24, 2026: $50M in new cafeteria infrastructure funding on top of $20M in Equipment Assistance Grants, up to $25M more in Patrick Leahy Farm to School awards for FY2026, and $30M in HHS nutrition research. Each pot has a different applicant, a different route, and a different timeline. Here is how to position for all three before the notices post.
Read article